但弗雷德里克森否认了所谓的诺基亚风险与诺和诺德之间的联系。诺和诺德的市值约为5,700亿美元，超过了丹麦的年度GDP。然而，弗雷德里克森在哥本哈根接受彭博电视采访时表示，丹麦经济在“相当长一段时间”内一直依赖熟练的劳动力和广泛成功的企业保持强劲。

Visa's stock closed more than 5% lower for the day. Senators grilled Novo Nordisk CEO Lars Fruergaard Jørgensen at a hearing on Tuesday over the high prices of the company's blockbuster injections.

During a tense hearing before a Senate committee on Tuesday, Novo Nordisk CEO Lars Fruergaard Jørgensen faced toug ...

In particular, semiconductor specialist Nvidia is viewed as the engine powering the AI vehicle right now. Demand for its most ...

While Congress debates the high cost of brand-name diabetes and weight loss drugs, Atlanta doctors are selling lower-cost alternatives made by compounding pharmacies.

For the millions of people living with diabetes or obesity, drugs like Ozempic and Wegovy can significantly improve their ...

Mount Sinai Health System is teaming up with a major health startup aimed at behavioral approaches to weight loss. The ...

Members of the Senate criticized the "outrageously high" prices for the popular weight loss drugs Ozempic and Wegovy. Sen. Bernie Sanders told Novo Nordisk, the manufacturer of the drugs, to stop ...

虽然联合治疗数据有可能在今年晚些时候推高诺和诺德的股价，但预期已经很高了。该股的远期市盈率为36倍。对于一家过去三年收益增长81%的公司来说，这是一个合理的价格，但前提是我们可以预期收益继续飙升。

The boss of the Danish pharmaceutical giant behind the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy promised Tuesday to examine lowering their prices in the United States, after ...

Novo Nordisk has been criticised by US politicians for the high pricing of its popular weight-loss and diabetes drugs. But ...

The head of Ozempic manufacturer Novo Nordisk on Tuesday defended the high price of the company’s highly sought-after obesity and Type 2 diabetes drugs, blaming pharma middlemen ...